This is the authors' abstract. We don't add key points for this paper.
c-Jun N-terminal kinase (JNK) regulates stress responses and affective behaviour, but the neural populations mediating these effects remain unclear. Here, we delivered a nucleus-targeted JNK inhibitor to the mouse brain using blood-brain barrier-crossing adeno-associated virus vectors with distinct cellular tropisms. JNK inhibition produced strikingly different behavioural outcomes depending on the neuronal populations targeted. Only AAV-PHP.eB-hSyn1-mediated delivery reproduced the previously reported anxiolytic phenotype, whereas AAV.CAP-B10-hSyn1 increased locomotor activity and depressive-like behaviour and AAV.CAP-B10-mDlx reduced locomotion while enhancing object recognition memory. The anxiolytic response was accompanied by reduced hilar mossy cell abundance and an approximately two-fold increase in doublecortin-positive newborn granule neurons in the dentate gyrus. Notably, this phenotype mirrors our previous findings following selective JNK inhibition in adult hippocampal progenitor cells, implicating the neurogenic niche as a convergent substrate for anxiolytic responses to JNK inhibition. Proteomic analysis of plasma extracellular vesicles revealed widespread alterations in metabolic and inflammatory proteins upon JNK inhibition, despite neuron-restricted transgene expression. Together, these findings demonstrate that the behavioural and systemic consequences of JNK inhibition depend critically on the neural populations targeted and identify hippocampal neurogenesis-associated circuits involving mossy cells as candidate mediators of JNK-dependent anxiety regulation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jokela et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: